ACTRN12606000343505招募中3 期
A Clinical trial comparing Cangrelor to Clopidogrel in subjects who require percutaneous coronary intervention (PCI) to demonstrate that cangrelor is superior, or at least non-inferior, to that of clopidogrel as measured by a composite of all-cause mortality, myocardial infarction (MI) and ischaemia driven revascularisation (IDR).
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 9,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Diagnostic coronary angiography demonstrating atherosclerosis amenable to treatment by PCI with or without stent implantation and one of the following:
- •1. Non ST segment myocardial infarction with Troponin I or T greater than upper limit of normal within 24 hours of randomisation.
- •2. Unstable angina with ischaemic chest discomfort occurring at rest and lasting longer than 10 minutes within 24 hours of randomisation and with dynamic ECG changes with age greater than 65 years or diabetes.
排除标准
- •Glycoprotein IIb/IIIa (GPI) Inhibitor usuage within the previous 12 hours.
研究者
相似试验
进行中（未招募）
1 期
A Clinical Trial Comparing Cangrelor To Clopidogrel In Subjects WhoRequire Percutaneous Coronary InterventionEnsayo clínico para comparar cangrelor con clopidogrel en sujetos que precisan una intervención coronaria percutánea - Champion PCIEUCTR2006-000192-14-ESThe Medicines Company
进行中（未招募）
不适用
A Clinical Trial Comparing Cangrelor To Clopidogrel In Subjects WhoRequire Percutaneous Coronary Intervention - Champion PCIEUCTR2006-000192-14-ATThe Medicines Company9,000
进行中（未招募）
不适用
A Clinical Trial Comparing Cangrelor To Clopidogrel In Subjects WhoRequire Percutaneous Coronary Intervention - Champion PCIEUCTR2006-000192-14-DEThe Medicines Company9,000
进行中（未招募）
不适用
A clinical trial comparing cangrelor to clopidogrel standard of care therapy in subjects who require percutaneous coronary intervention - PhoenixEUCTR2010-021591-28-ITTHE MEDICINES COMPANY10,900
进行中（未招募）
不适用
A clinical trial comparing cangrelor to clopidogrel in subjects who require percutaneous coronary intervention. - NDSubjects with coronary atherosclerosis who require PCI (with or without stent).MedDRA version: 6.1Level: PTClassification code 10011076EUCTR2006-000192-14-ITTHE MEDICINES COMPANY UK9,000